332 related articles for article (PubMed ID: 36721212)
1. Reprogramming the tumor microenvironment with biotechnology.
Kim M; Lee NK; Wang CJ; Lim J; Byun MJ; Kim TH; Park W; Park DH; Kim SN; Park CG
Biomater Res; 2023 Jan; 27(1):5. PubMed ID: 36721212
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
[TBL] [Abstract][Full Text] [Related]
4. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
Zhang M; Wei T; Zhang X; Guo D
Front Immunol; 2022; 13():937406. PubMed ID: 36131916
[TBL] [Abstract][Full Text] [Related]
5. Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment.
Cheng H; Zheng Y
PeerJ; 2024; 12():e16825. PubMed ID: 38239299
[TBL] [Abstract][Full Text] [Related]
6. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38811773
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Reprogramming in Tumor Immune Microenvironment: Impact on Immune Cell Function and Therapeutic Implications.
Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
Cancer Lett; 2024 Jun; ():217076. PubMed ID: 38906524
[TBL] [Abstract][Full Text] [Related]
8. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints.
Xu Y; He L; Fu Q; Hu J
Front Oncol; 2021; 11():759015. PubMed ID: 34858835
[TBL] [Abstract][Full Text] [Related]
10. Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint.
Verma NK; Wong BHS; Poh ZS; Udayakumar A; Verma R; Goh RKJ; Duggan SP; Shelat VG; Chandy KG; Grigoropoulos NF
EBioMedicine; 2022 Sep; 83():104216. PubMed ID: 35986950
[TBL] [Abstract][Full Text] [Related]
11. Regulatory effects of IRF4 on immune cells in the tumor microenvironment.
Lu J; Liang T; Li P; Yin Q
Front Immunol; 2023; 14():1086803. PubMed ID: 36814912
[TBL] [Abstract][Full Text] [Related]
12. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
14. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
15. A role for platelets in metabolic reprogramming of tumor-associated macrophages.
Kang Y; Amoafo EB; Entsie P; Beatty GL; Liverani E
Front Physiol; 2023; 14():1250982. PubMed ID: 37693009
[TBL] [Abstract][Full Text] [Related]
16. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy.
Wegiel B; Vuerich M; Daneshmandi S; Seth P
Front Oncol; 2018; 8():284. PubMed ID: 30151352
[TBL] [Abstract][Full Text] [Related]
18. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
19. [Research Progress and New Immunotherapy Strategies of Tumor Microenvironment Metabolism].
Peng YM; Luo XM; Chen JY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):505-509. PubMed ID: 37248575
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]